Cencora Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $332.8B+13.2% YoYTTM through 30 Jun 2026
Net Income $2.6B+73.9% YoYTTM through 30 Jun 2026
Free Cash Flow $4.1BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 4.0% |
| EBITDA Margin | 1.2% |
| Operating Margin | 0.9% |
| Net Margin | 0.8% |
Returns
86.0%ROE
3.1%ROA
21.9%ROIC
Balance Sheet Health
Debt / Equity3.84x
Current Ratio0.93x
Net Debt$8.9B
Cash & Equivalents$2.8B
Quality Metrics
Altman Z-Score4.63
Piotroski F-Score8 / 9
FCF Margin1.2%
Rule of 402.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $321.3B
Diluted EPS$13.47TTMFY2025: $7.96
Dividend
$2.06Per share, FY20260.65%Yield1 yrsStreak-8.9%5-yr growth
Capital Allocation
Capex Intensity0.2%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.